0000000000023313

AUTHOR

Fabio Corsi

0000-0002-6469-4086

showing 3 related works from this author

Acute parathyroid hormone increase by oral peptones administration after roux-en-Y gastric bypass surgery in obese subjects: Role of phosphate in the…

2010

It is generally considered that changes in serum phosphate levels do not alter parathyroid hormone (PTH) secretion in the absence of concomitant changes in ionized serum calcium level in humans. An acute rise in PTH was shown after phosphate administration by intraduodenal gavage in rats. We aimed to study gastrin, phosphate, PTH, ionized calcium (iCa), and blood pH responses to oral peptones in morbidly obese patients before and after roux-en-Y gastric bypass (RYGB) surgery.These parameters were evaluated in response to an oral peptone load in 24 (18 male and 6 female) obese subjects before and 6 months after RYGB surgery. In 12 gastric bypass patients, we also evaluated PTH and phosphate …

AdultMalemedicine.medical_specialtyGastric BypassAdministration OralParathyroid hormonechemistry.chemical_elementAluminum HydroxideCalciumgastric bypass phosphate parathyroid hormone ionized calcium peptonesmedicine.disease_causePhosphatesJejunumYoung Adultchemistry.chemical_compoundInternal medicineGastrinsmedicineHumansPostoperative PeriodProspective StudiesGastrinCalcium metabolismGastrointestinal tractGastric bypass surgerybusiness.industryHydrogen-Ion ConcentrationPhosphateObesity MorbidJejunumEndocrinologymedicine.anatomical_structureIntestinal AbsorptionchemistryParathyroid HormonePeptonesCalciumFemaleSurgerybusinesshormones hormone substitutes and hormone antagonistsSurgery
researchProduct

PARATHYROID HORMONE INCREASES AFTER ORAL PEPTONES ADMINISTRATION IN OBESE SUBJECTS TREATED WITH ROUX-EN-Y GASTRIC BYPASS SURGERY: ROLE OF PHOSPHATE O…

2008

Settore MED/09 - Medicina InternaPARATHYROID HORMONE GASTRIC BYPASS PHOSPHATE
researchProduct

Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.

2021

Abstract Emerging evidence indicates that gut microbiota affect the response to anticancer therapies by modulating the host immune system. In this study, we investigated the impact of gut microbiota on immune-mediated trastuzumab antitumor efficacy in preclinical models of HER2-positive breast cancer and in 24 patients with primary HER2-positive breast cancer undergoing trastuzumab-containing neoadjuvant treatment. In mice, the antitumor activity of trastuzumab was impaired by antibiotic administration or fecal microbiota transplantation from antibiotic-treated donors. Modulation of the intestinal microbiota was reflected in tumors by impaired recruitment of CD4+ T cells and granzyme B–posi…

0301 basic medicineCD4-Positive T-LymphocytesCancer ResearchReceptor ErbB-2medicine.medical_treatmentGut floraGranzymesMice0302 clinical medicineAntineoplastic Agents ImmunologicalTrastuzumabTumor Microenvironmentskin and connective tissue diseasesNeoadjuvant therapybiologyFecal Microbiota TransplantationInterleukin-12Neoadjuvant TherapyAnti-Bacterial AgentsTreatment OutcomeOncology030220 oncology & carcinogenesisStreptomycinCytokinesGut microbiota trastuzumab breast cancerFemaleTaxoidsmedicine.drugBridged-Ring CompoundsBreast NeoplasmsSettore MED/08 - Anatomia PatologicaNitric Oxide03 medical and health sciencesImmune systemBreast cancerVancomycinmedicineAnimalsHumansCyclophosphamideImmunity Mucosalbusiness.industryLachnospiraceaeDendritic cellDendritic CellsTrastuzumabbiology.organism_classificationmedicine.diseaseGastrointestinal Microbiome030104 developmental biologyGranzymeDoxorubicinImmune Systembiology.proteinCancer researchInterferonsbusinessCancer research
researchProduct